Title |
Hyaluronic acid dermal fillers: can adjunctive lidocaine improve patient satisfaction without decreasing efficacy or duration?
|
---|---|
Published in |
Patient preference and adherence, March 2011
|
DOI | 10.2147/ppa.s11251 |
Pubmed ID | |
Authors |
Lynnelle Smith, Kimberly Cockerham |
Abstract |
Hyaluronic acid (HA) dermal fillers are the most widely used injectables to augment facial volume without surgery. HA dermal fillers are popular because of their ease of administration, predictable effectiveness, good safety profile, and quick patient recovery. The most common patient complaint is pain. Our goal is to review the current literature on HA fillers and compare outcomes with and without lidocaine. We found adjunctive lidocaine significantly decreases pain during injection and postinjection with corresponding increased patient satisfaction. The efficacy and safety profile appears unchanged. Rare complications with HA fillers and those associated with constituents of the product, contaminants, and lidocaine are reviewed. The corrective effects of HA fillers are temporary; repeat treatment is required to maintain results. Minimizing pain is crucial to optimize patient satisfaction. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 63 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 12 | 19% |
Researcher | 6 | 10% |
Student > Doctoral Student | 5 | 8% |
Other | 5 | 8% |
Student > Postgraduate | 5 | 8% |
Other | 9 | 14% |
Unknown | 21 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 24 | 38% |
Biochemistry, Genetics and Molecular Biology | 5 | 8% |
Agricultural and Biological Sciences | 4 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
Social Sciences | 1 | 2% |
Other | 3 | 5% |
Unknown | 23 | 37% |